Zhejiang Jinliyuan Pharmaceutical

Zhejiang Jinliyuan Pharmaceutical Co., Ltd. (also known as Zhejiang Kinglyuan Pharmaceutical) is a pharmaceutical company based in Xinchang, China, and is a subsidiary of the Zhejiang Jingxin Pharmaceutical Group. The company specializes in the research, development, and large-scale production of active pharmaceutical ingredients (APIs), chemical synthetic drugs, and modern traditional Chinese medicines (TCM). Its therapeutic focus includes cardiovascular diseases, metabolic disorders, and anti-infectives, with a product portfolio featuring drugs such as Irbesartan and Cilostazol. Jinliyuan operates a dedicated scientific research center that collaborates with prominent academic institutions to advance its pipeline of generic and innovative therapies. The company's manufacturing facilities are GMP-certified, supporting its operations in both domestic and international markets.